Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Vortioxetine is a novel antidepressant capable of improving depressive and cognitive symptoms associated with major depressive disorder (MDD). This study established whether treatment with vortioxetine, fluoxetine or vehicle alters the modulation of brain-derived neurotrophic factor (BDNF) under the 21-day chronic unpredictable mild stress (CUMS) condition in 54 Sprague-Dawley rats. Vortioxetine mitigated the reduction in rearing behavior by CUMS in the OFT on day 7 and 21, as well as sucrose preference on day 21. Histological examination by H&E staining showed that most hippocampal neurons in the CUMS + FLU and CUMS + VOR groups were intact, although some of them demonstrated karyopyknosis. The mean optical density value of hippocampal BDNF was significantly higher in the CUMS + VOR group than the CUMS and CUMS + FLU groups. There was a trend towards a higher number of hippocampal BDNF-positive cells in the CUMS + VOR group, although it did not reach statistical significance. In conclusion, vortioxetine, but not fluoxetine, increased hippocampal BDNF levels in rats subject to CUMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“, 2014), while increased brain BDNF levels are associated with antidepressant effects (Nibuya et al., 1995).”
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · cited 1×
“Animals were given one type of stimulus at a random time every day, to ensure that the stress was unpredictable in terms of time and manner (Willner et al., 1987).”
McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Self-citationOPEN‐FIELD BEHAVIOR IN THE RAT: WHAT DOES IT MEAN?*
Denenberg, V. H. (1969) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1969.tb12983.x · Cited by 582
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547 · cited 1×
“Indeed, the significant improvement in exploratory and locomotor behavior observed in the CUMS+VOR group could be attributed to an increase in serotonin and reduction in gammaAminobutyric acid neurotransmission (Sanchez et al., 2015).”
Animal model of depression: Pharmacological sensitivity of a hedonic deficit
Katz, R. J. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90053-3 · Cited by 480
Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390 · cited 8×
“Previous studies demonstrated that the reduction of brain BDNF levels may presage MDD (Garcia et al., 2008; Zhou et al., 2014), while increased brain BDNF levels are associated with antidepressant effects (Nibuya et al., 1995).”
InfluentialMcIntyre, R., Harrison, J., Loft, H., Jacobson, W., & Olsen, C. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw055 · Cited by 185 · cited 1×
“Vortioxetine is a novel multimodal antidepressant that has demonstrated significant improvement in cognitive function when compared to other antidepressants (McIntyre et al., 2016), although the neurobiological mechanisms underlying the precognitive effects of this agent are not fully understood.”
Self-citationEfficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder
McIntyre, R. S., Florea, I., Tonnoir, B., Loft, H., Lam, R. W., & Christensen, M. C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m10744 · Cited by 100 · cited 7×
“Previous studies demonstrated that the reduction of brain BDNF levels may presage MDD (Garcia et al., 2008; Zhou et al., 2014), while increased brain BDNF levels are associated with antidepressant effects (Nibuya et al., 1995).”
InfluentialSelf-citationJensen, J. B., du Jardin, K. G., Song, D., Budac, D., Smagin, G., Sanchez, C., & Pehrson, A. L. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.011 · Cited by 96 · cited 2×
“The effects of vortioxetine on depression-like behavior and cognitive impairment are different from selective serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) in animal models of depression (Jensen et al., 2014).”
Cited by
Cognitive impairment in depression: recent advances and novel treatments
Perini, G., Cotta Ramusino, M., Sinforiani, E., Bernini, S., Petrachi, R., & Costa, A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199746 · Cited by 384
Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder
Husain, S. F., Yu, R., Tang, T.-B., Tam, W. W., Tran, B., Quek, T. T., Hwang, S.-H., Chang, C. W., Ho, C. S., & Ho, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-66784-2 · Cited by 213
Self-citationAlmeida, R. N. D., Galvão, A. C. D. M., da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., de Araújo, L.-S. B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01234 · Cited by 177
The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes
Ross, R. E., VanDerwerker, C. J., Saladin, M. E., & Gregory, C. M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01819-w · Cited by 176
Cao, B., Zhu, J., Zuckerman, H., Rosenblat, J. D., Brietzke, E., Pan, Z., Subramanieapillai, M., Park, C., Lee, Y., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.002 · Cited by 175
“These drugs are taken chronically which could potentiate more sensitive dopaminergic response (Maj et al., 1984).”
BackgroundSelf-citation
Metadata
- Authors
- Lu, Y., Ho, C. S., McIntyre, R. S., Wang, W., & Ho, R. C.
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 142
- Pages
- 1-7
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W2809208927
- Cited by
- 90
- References
- 11
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats. https://app.cochat.ai/papers/10.1016/j.brainresbull.2018.06.007
- The paper
- Lu, Y., Ho, C. S., McIntyre, R. S., Wang, W., & Ho, R. C. (2018). Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats. Brain Research Bulletin. https://doi.org/10.1016/j.brainresbull.2018.06.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.